Medical Oncology Fellowship Program

肿瘤内科奖学金计划

• 批准号: 8554192
• 负责人: Antonio Fojo
• 金额: $ 631.85万
• 依托单位: DIVISION OF BASIC SCIENCES - NCI
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/8554192
• 关键词: Acquired Immunodeficiency Syndrome; Adult; Advertising; Ambulatory Care; American Cancer Society; American Society of Clinical Oncology; Anti-Retroviral Agents; Appointment; Area; Basic Science; Bone Marrow Examination; Cancer Control; Cancer Vaccines; Caring; Centers for Disease Control and Prevention (U.S.); Charge; Clinic; Clinical; Clinical Medicine; Clinical Oncology; Clinical Research; Clinical Sciences; Clinical Trials; Coagulation Process; Collaborations; Communities; Conduct Clinical Trials; Consult; Consultations; Critical Care; Development; Diagnostic Procedure; Disease; Division of Cancer Prevention; Drug Industry; Educational Curriculum; Educational process of instructing; Enrollment; Ensure; Family; Fellowship; Fellowship Program; Fostering; Germ cell tumor; Goals; Government; Hematologic Neoplasms; Hematology; Hodgkin Disease; Hospital Referrals; Hospitals; Hour; Human; Human Resources; Individual; Inpatients; Joints; Journals; Laboratories; Laboratory Research; Lymphoma; Malignant - descriptor; Malignant Neoplasms; Malignant neoplasm of ovary; Malignant neoplasm of prostate; Maryland; Medial; Medical; Medical Oncologist; Medical Oncology; Medical Staff; Medical center; Medicine; Mentors; Military Personnel; National Cancer Institute; National Heart, Lung, and Blood Institute; Oncologist; Operative Surgical Procedures; Outpatients; Paracentesis; Participant; Pathology; Patients; Physicians; Population; Positioning Attribute; Process; Radiation Oncology; Recruitment Activity; Renal Cell Carcinoma; Research; Research Personnel; Rotation; Scientist; Series; Services; Solid Neoplasm; Spouses; Stem cell transplant; System; Thoracentesis; Time; Training; Training Programs; Transfusion; Transplantation; United States; United States National Institutes of Health; Walking; Washington; age group; anticancer research; cancer therapy; career; chemotherapy; chronic leukemia; clinical care; clinical conference; design; disease characteristic; disorder prevention; drug testing; experience; interest; lectures; leukemia; malignant breast neoplasm; meetings; member; multidisciplinary; neoplastic; novel strategies; oncology; patient population; programs; research study; skills; symposium; ward; young adult

The Fellowship Training Program in Adult Medical Oncology at the National Cancer Institute is a unified teaching experience in clinical oncology and research that is conducted at the National Cancer Institute (NCI) and the National Naval Medical Center (NNMC), Bethesda, Maryland. This Fellowship Program provides an unique opportunity for physicians interested in academic careers to develop and integrate both their clinical and basic research interests. The clinical portion of the Fellowship consists of primary responsibility for the clinical care of inpatients and outpatients with a board spectrum of adult malignancies. It introduces the participants to the process of designing and conducting clinical trials. During the first clinical year, there is an emphasis on exposing fellows to the basic science and clinical medicine of oncology. During the research years, the fellow will join one of the several hundred available investigators within the National Cancer Institute to acquire the skills necessary to become an independent biomedical investigator with emphasis on laboratory or clinical science. The NCI guarantees at least two years of protected research time to all of its medical oncology fellows. The goal of the Program is to foster the development of physician-scientists who have excellent clinical and research skills.During the first year of Medical Oncology training, Fellows devote 100% of their time to clinical training in inpatient and outpatient care. All first year fellows spend six months at the NIH Clinical Center (NIH-CC) and six months at the NNMC. In the second and third years, 20% of the fellows' time is spent in the care of outpatients in either the NIH-CC or NNMC. This continuity clinic ensures that fellows in the program extend their experience with a wide spectrum of human cancer. The remaining time in the second and third years is protected time for research in any of the NCI Clinical Teams or any NIH laboratory. The NIH-CC emphasizes the development of new approaches to the treatment of cancer and its complications. Current areas of clinical emphasis include prostate cancer, ovarian cancer, renal cell carcinoma, lymphomas, Hodgkin's disease, chronic leukemia, new drug testing, stem cell transplantation and AIDS, and its associated malignancies. Patients with AIDS and AIDS associated malignancies constitute approximately 15% of the total patient population; nearly all these patients are involved in studies of experimental antiretroviral compounds and chemotherapy. Training in clinical diagnostic procedures such as bone marrow examination, thoracentesis, and paracentesis is a routine part of the first-year experience. Collaboration with related clinical units in the Clinical Center such as Radiation Oncology, Surgery, and Critical Care Medicine is very close.The NNMC is located in Bethesda, adjacent to the NIH campus. It is a tertiary referral hospital that serves active duty military personnel and their families, retired military and their spouses, and some embassy, Congressional, and other non-military government personnel. Patients are referred from the military system around the world with all types of malignant disease, including solid tumors and hematological malignancies. There is a large population of young adults with malignant diseases characteristic of this age group (e.g. germ cell tumors). The program provides consultation in oncology and hematology to the NNMC and treatment for DOD patients with cancer. In addition, civilian patients who are eligible for NCI studies can be admitted to the program for care and study. The studies at NNMC have focused on breast cancer, prostate cancer and cancer vaccines. Roughly 8% of patients enrolled are on NCI clinical trials and 92% of patients are involved in standard oncologic management.The Medial Oncology Branch also has a joint Hematology/Oncology Training Program in collaboration with the Hematology Branch, National Heart, Lung, and Blood Institute, and the Hematology Department, Clinical Center, NIH. This program combines the separate training programs of hematology and medical oncology into a series of clinical rotations encompassing the first 18 or 22 months of fellow's training. Fellows whose principal interest is hematology have a primary appointment in the NHLBI and their chief clinical exposure is in clinical hematology but includes six months of clinical oncology in the Medical Oncology Branch, NCI. Fellows who have a primary interest in medical oncology have their appointment with the NCI. Their principal clinical exposure is in clinical oncology with an additional six months of hematology rotations. The first 12 months of training are exactly like that for medical oncology-alone. In the second year they undertake an additional 6 months of clinical hematology that usually includes the following: 2 months ward hematology (NHLBI), 1 month leukemia service (Johns Hopkins Transplant Unit), 2 weeks transfusion medicine, 6 weeks consult hematology and coagulation, and 1 month rotation at the Washington VA Hospital. Following completion of this 18-month clinical period, the fellow does laboratory or clinical research for up to 4 years of fellowship along with continued outpatient clinical duties. Offered throughout the Program are lectures, research seminars, conferences, journal club, teaching rounds and conferences relevant to clinical oncology and cancer research. Most of these are organized specifically for medical staff fellows. These include a core curriculum lecture series in clinical oncology, which meets once a week throughout the year, and offers lectures by members of the senior staff across the spectrum of issues in neoplastic disease. At both the NIH-CC and the NNMC, the formal didactic lectures and teaching rounds total approximately 10 hours per week. Fellows are responsible for preparing case presentations and lecture material for about 33% of the lecture time. Pathology teaching sessions are held in both the NIH-CC and NNMC in addition to multidisciplinary clinical conferences, walk rounds, and a variety of disease specific multidisciplinary meetings. In addition, there are 10 to 15 research seminars and lectures given per day throughout the NIH; these are advertised in a weekly announcement and are regularly open to the entire NIH community.

国家癌症研究所成人医学肿瘤学研究员培训项目是临床肿瘤学和研究的统一教学经验，在国家癌症研究所 (NCI) 和马里兰州贝塞斯达国家海军医疗中心 (NNMC) 进行。该奖学金计划为对学术职业感兴趣的医生提供了一个独特的机会，以发展和整合他们的临床和基础研究兴趣。 该奖学金的临床部分主要负责住院和门诊患有各种成人恶性肿瘤的患者的临床护理。 它向参与者介绍了设计和进行临床试验的过程。 在第一个临床年，重点是让研究员接触肿瘤学的基础科学和临床医学。 在研究期间，该研究员将加入国家癌症研究所的数百名研究人员之一，以获得成为一名独立的生物医学研究人员所需的技能，重点是实验室或临床科学。 NCI 保证所有肿瘤内科研究员至少有两年受保护的研究时间。 该计划的目标是培养具有出色临床和研究技能的医师科学家。在肿瘤内科培训的第一年，研究员将 100% 的时间投入到住院和门诊护理的临床培训中。 所有一年级研究员在 NIH 临床中心 (NIH-CC) 学习六个月，在 NNMC 学习六个月。在第二年和第三年，研究员 20% 的时间花在 NIH-CC 或 NNMC 的门诊患者护理上。 这个连续性诊所确保该项目的研究员扩展他们在广泛的人类癌症方面的经验。 第二年和第三年的剩余时间是在任何 NCI 临床团队或任何 NIH 实验室进行研究的受保护时间。 NIH-CC 强调开发治疗癌症及其并发症的新方法。 目前临床重点领域包括前列腺癌、卵巢癌、肾细胞癌、淋巴瘤、霍奇金病、慢性白血病、新药检测、干细胞移植和艾滋病及其相关恶性肿瘤。 患有艾滋病和艾滋病相关恶性肿瘤的患者约占患者总数的 15%；几乎所有这些患者都参与了实验性抗逆转录病毒化合物和化疗的研究。 骨髓检查、胸腔穿刺术和腹腔穿刺术等临床诊断程序培训是第一年经验的常规部分。 与临床中心的放射肿瘤科、外科、重症监护医学等相关临床单位的合作非常密切。NNMC 位于贝塞斯达，毗邻 NIH 校区。 这是一家三级转诊医院，为现役军人及其家人、退役军人及其配偶以及一些大使馆、国会和其他非军事政府人员提供服务。 患者从世界各地的军事系统转诊而来，患有各种类型的恶性疾病，包括实体瘤和血液恶性肿瘤。 有大量年轻人患有该年龄段特有的恶性疾病（例如生殖细胞肿瘤）。 该计划向 NNMC 提供肿瘤学和血液学咨询，并为 DOD 癌症患者提供治疗。 此外，符合 NCI 研究资格的平民患者也可以加入该计划接受护理和研究。 NNMC 的研究重点是乳腺癌、前列腺癌和癌症疫苗。 大约 8% 的入组患者参加 NCI 临床试验，92% 的患者参与标准肿瘤学管理。内侧肿瘤科还与血液科、国家心肺血液科合作开展血液学/肿瘤学联合培训计划研究所和血液科、临床中心、NIH。 该计划将血液学和肿瘤内科的单独培训计划结合到一系列临床轮转中，涵盖研究员培训的前 18 或 22 个月。 主要兴趣是血液学的研究员在 NHLBI 拥有主要任命，他们的主要临床接触是临床血液学，但包括在 NCI 内科肿瘤学分部进行六个月的临床肿瘤学。主要对肿瘤内科感兴趣的研究员将与 NCI 预约。 他们的主要临床接触是临床肿瘤学，另外还有六个月的血液学轮转。 前 12 个月的培训与单纯肿瘤内科培训完全相同。 第二年，他们额外进行 6 个月的临床血液学，通常包括以下内容：2 个月的病房血液学 (NHLBI)、1 个月的白血病服务（约翰霍普金斯大学移植科）、2 周的输血医学、6 周的血液学和凝血咨询、以及在华盛顿退伍军人医院 (Washington VA Hospital) 轮转 1 个月。 完成 18 个月的临床期后，研究员将进行长达 4 年的实验室或临床研究，并继续承担门诊临床职责。该计划提供与临床肿瘤学和癌症研究相关的讲座、研究研讨会、会议、期刊俱乐部、教学查房和会议。 其中大部分是专门为医务人员组织的。 其中包括临床肿瘤学核心课程讲座系列，该课程全年每周举行一次，并由高级工作人员就肿瘤疾病的各个问题进行讲座。 在 NIH-CC 和 NNMC，正式的教学讲座和教学轮次总计每周大约 10 个小时。 研究员约 33% 的讲座时间负责准备案例演示和讲座材料。 除了多学科临床会议、巡回查房和各种特定疾病的多学科会议外，NIH-CC 和 NNMC 还举办病理学教学课程。 此外，NIH 每天举办 10 至 15 场研究研讨会和讲座；这些内容在每周公告中发布，并定期向整个 NIH 社区开放。